In pancreatic ductal adenocarcinoma cell lines, they report a negative regulation of GPR55 with TP53 status, where overexpression of wild-type p53 in the AsPC-1 cell line (harbouring a TP53 mutation) caused a reduction in GPR55 expression. Here, GPR55 is linked to pancreatic ductal adenocarcinoma.